Latest news with #CHF106.00


Business Insider
16-07-2025
- Business
- Business Insider
Kepler Capital Sticks to Their Buy Rating for Novartis AG (NOVN)
Kepler Capital analyst David Evans maintained a Buy rating on Novartis AG on July 14 and set a price target of CHF106.00. The company's shares closed yesterday at CHF96.06. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Evans is a 2-star analyst with an average return of 0.1% and a 55.72% success rate. Evans covers the Healthcare sector, focusing on stocks such as Roche Holding AG, Novartis AG, and Novo Nordisk. Novartis AG has an analyst consensus of Moderate Buy, with a price target consensus of CHF102.20, a 6.39% upside from current levels. In a report released on July 4, Deutsche Bank also maintained a Buy rating on the stock with a CHF115.00 price target. Based on Novartis AG's latest earnings release for the quarter ending March 30, the company reported a quarterly revenue of CHF13.62 billion and a net profit of CHF3.61 billion. In comparison, last year the company earned a revenue of CHF12.12 billion and had a net profit of CHF2.69 billion


Business Insider
27-04-2025
- Business
- Business Insider
Kepler Capital Reaffirms Their Buy Rating on Holcim (0QKY)
In a report released on April 25, Prieto Luis from Kepler Capital maintained a Buy rating on Holcim (0QKY – Research Report), with a price target of CHF106.00. The company's shares closed last Friday at CHF41.60. Stay Ahead of the Market: Discover outperforming stocks and invest smarter with Top Smart Score Stocks. Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener. According to TipRanks, Luis is ranked #189 out of 9371 analysts. Holcim has an analyst consensus of Hold, with a price target consensus of CHF95.64. 0QKY market cap is currently CHF50.64B and has a P/E ratio of 17.20. Based on the recent corporate insider activity of 28 insiders, corporate insider sentiment is neutral on the stock.